Dyne Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	3,392	816	604	613	954
Market Cap Growth	258.51%	35.11%	-1.39%	-35.80%	-
Enterprise Value	2,963	718	376	266	609
PE Ratio	-	-3.46	-3.59	-4.10	-16.06
PB Ratio	7.09	8.94	2.39	1.66	2.79
P/FCF Ratio	-10.55	-4.32	-3.86	-4.97	-20.02
P/OCF Ratio	-10.59	-4.34	-3.93	-5.12	-20.52
EV/EBITDA Ratio	-7.44	-3.08	-2.28	-1.79	-10.44
EV/EBIT Ratio	-7.37	-3.04	-2.24	-1.78	-10.32
EV/FCF Ratio	-8.61	-3.80	-2.40	-2.16	-12.78
Debt / Equity Ratio	0.06	0.30	0.12	0.09	-
Debt / EBITDA Ratio	-0.10	-0.12	-0.19	-0.22	-
Debt / FCF Ratio	-0.12	-0.15	-0.19	-0.26	-
Quick Ratio	20.37	2.45	9.20	13.19	31.49
Current Ratio	21.83	2.53	9.46	13.31	31.83
Interest Coverage	-	-	-	-	-149.09
Return on Equity (ROE)	-110.90%	-136.40%	-59.70%	-34.90%	-33.40%
Return on Assets (ROA)	-90.00%	-103.70%	-50.40%	-32.30%	-32.10%
Return on Capital (ROIC)	-52.68%	-204.00%	-60.44%	-37.43%	-17.13%
Earnings Yield	-7.59%	-28.90%	-27.82%	-24.37%	-6.23%
FCF Yield	-6.50%	-23.14%	-25.94%	-20.11%	-4.99%
Buyback Yield / Dilution	-43.88%	-14.83%	-2.12%	-253.54%	-489.30%
Total Shareholder Return	-43.88%	-14.83%	-2.12%	-253.54%	-489.30%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).